Hope To Seaview 2025
Join Colin and Linda McArthur for their annual Isle of Wight walk, in aid of Retina UK's 50th anniversary.
Search
Search results
Hope To Seaview 2024
Join Colin & Linda McArthur for their annual Isle of Wight walk in support of Retina UK. Last year's event raised a record-breaking £6,000+!
FAQs: Luxturna (voretigene neparvovec)
Luxturna, a gene therapy, is only for the treatment of Leber congenital amaurosis type 2 (LCA2) and severe early-onset RP caused by mutations in a specific gene called RPE65.
Our commitment to lived experience employment
In April 2022 we joined with another seven leading sight loss organisations to make a public commitment to increasing the number of blind and partially sighted people employed within our sector, including at senior management level.
Kathy Evans, Chair of Trustees
Kathy joined Retina UK as Chair of Trustees in September 2024.
Frequently asked questions
These are some of the most commonly asked questions about genetic testing and counselling.
Meet a Researcher: Dr Rachel Taylor
Dr Rachel Taylor is part of the UK Inherited Retinal Dystrophy Consortium (UKIRDC) team at the University of Manchester.
Meet a Researcher: Tomasz Tomkiewicz
Tomasz Tomkiewicz is undertaking a PhD studentship funded by Retina UK and The Macular Society.
Completed Research Project Outcomes
The following projects were being funded by Retina UK and have recently come to an end.
Growth factors
Growth factors are substances that promote the health and function of cells and tissues in the body.